CA
RVMD icon

Clearstead Advisors’s Revolution Medicines RVMD Stock Holding History

Clearstead Advisors’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$714K Buy
3,813
+966
+34% +$141K 0.01% 645
2026
Q1 		$277K Buy
2,847
+17
+0.6% +$1.72K ﹤0.01% 890
2025
Q4 		$225K Buy
2,830
+2,730
+2,730% +$179K ﹤0.01% 907
2025
Q3 		$4.67K Sell
100
-27
-21% -$1.06K ﹤0.01% 2181
2025
Q2 		$4.67K Hold
127
– – ﹤0.01% 2124
2025
Q1 		$4.49K Hold
127
– – ﹤0.01% 1771
2024
Q4 		$5.55K Buy
127
+27
+27% +$1.36K ﹤0.01% 1697
2024
Q3 		$4.54K Hold
100
– – ﹤0.01% 1721
2024
Q2 		$3.88K Hold
100
– – ﹤0.01% 1725
2024
Q1 		$3.72K Buy
+100
New +$2.96K ﹤0.01% 1216

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Clearstead Advisors's RVMD Position: Q2 2026 in Review

Clearstead Advisors increased its Revolution Medicines (RVMD) stake by 34% in Q2 2026, buying an estimated $141K and bringing the position to 3,813 shares worth $714K. The position accounts for 0.01% of the portfolio, ranked #645.

Clearstead Advisors first reported a position in RVMD in Q1 2024 and has held it in 10 quarters since. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Clearstead Advisors held 3,813 shares of Revolution Medicines worth $714K as of Q2 2026.
  • Clearstead Advisors bought 966 Revolution Medicines shares in Q2 2026, an estimated $141K.
  • Revolution Medicines made up 0.01% of Clearstead Advisors's portfolio in Q2 2026, its #645 holding.
  • Clearstead Advisors first reported a position in Revolution Medicines in Q1 2024 and has held it in 10 quarters since.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.